RMTI
ROCKWELL MEDICAL, INC.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 8 Rockwell Medical received a Nasdaq delisting notice on May 8, 2026 f…
- S Oct 1 1 insider sell $8.4K at $8.42
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $8.4K.
- InstitutionsMIXED
Q2 2026: 0 added (0 new), 2 trimmed or exited.
- AnalystsBULLISH
7 of 8 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate −$0.150 → −$0.180 over 90 days. 0 up, 1 down in 30 days.
- TrendDOWNTREND
12% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $198.0K |
| BlackRock, Inc. | TRIM | $79.7K |
| RENAISSANCE TECHNOLOGIES LLC | ADD | $570.9K |
| GROUP ONE TRADING LLC | DOUBLED | $262.00 |
| UBS Group AG | DOUBLED | $116.5K |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | $478.00 |
| JONES FINANCIAL COMPANIES LLLP | NEAR_EXIT | $215.00 |
| PANAGORA ASSET MANAGEMENT INC | ADD | $82.3K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
8 analystsPrice is below the lowest target. Median implies +186%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. REITERATE | Buy |
| Jul 9, 2026 | HC Wainwright & Co. MAINTAIN | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 1, 2026 | Strobeck Mark President and CEO | SELL | $8.4K |
| Jul 1, 2026 | Dawson Joseph H Director | AWARD | 9,633 sh |
| Jul 1, 2026 | Nissenson Allen Director | AWARD | 9,633 sh |
| Jul 1, 2026 | Lau Joan Director | AWARD | 9,633 sh |
| Jul 1, 2026 | Radie Robert S Director | AWARD | 9,633 sh |
| Jul 1, 2026 | COOPER JOHN G Director | AWARD | 9,633 sh |
| Jul 1, 2026 | TIMMINS MEGAN C. EVP, CLO & Secretary | AWARD | 15,000 sh |
| Jul 1, 2026 | Neri Jesse SVP and CFO | AWARD | 15,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.18 | -$0.23–-$0.13 | -9.1% | $18.2M |
| Next Q | -$0.11 | -$0.15–-$0.07 | +12.0% | $19.0M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
5 filings · 0 bullish · 1 bearish · 4 neutral- NEUTRAL 8-KAug 13, 2026
Rockwell Medical, Inc. filed an 8-K on August 13, 2026, disclosing an updated corporate…
Monitor for any subsequent filings or press releases that may contain the actual content of the updated corporate presentation. Without the presentation, there is no actionable information from this…
- NEUTRAL 8-KJul 20, 2026
Rockwell Medical announced it has regained compliance with Nasdaq's minimum bid price requirement…
The delisting risk is resolved, which removes a near-term catalyst for forced selling or volatility. However, the stock remains near the $1 threshold, and the company's underlying business…
- NEUTRAL 8-KJun 29, 2026
Rockwell Medical filed an 8-K announcing a 1-for-10 reverse stock split effective July 1, 2026…
Monitor post-split trading for liquidity and potential Nasdaq compliance benefits. No immediate catalyst for price movement; the split is a mechanical adjustment.
- BEARISH 8-KMay 8, 2026
Rockwell Medical received a Nasdaq delisting notice on May 8, 2026 for failing to meet the $1.00…
Monitor the 2026 annual meeting proxy vote on the reverse stock split—approval is critical for regaining compliance. The stock may face selling pressure leading up to the November 4 deadline if no…
All RMTI filing & press-release reports (5)
- 8-K reportAug 13, 2026
- 8-K reportJul 20, 2026
- 8-K reportJun 29, 2026
- 8-K reportMay 8, 2026
- 8-K reportMay 7, 2026